Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Meropenem in Sepsis
NCT03344627Completed
- Sponsor
- Mahidol University
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of meropenem in sepsis and septic shock (2 arms), sponsored by Mahidol University. Primary endpoint: Sequential Organ Failure Assessment Score Change at Day 4. Started Nov 2017; status: completed.
02
Drugs
meropenem
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT03344627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03344627.